Registered Nurse in Bethel, VT Accepting Medicare
1 Registered Nurse nurses found. Showing 1 - 1
 Eva Linden, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1823 Vt Rte 107, Bethel, VT 05032 Phone: 802-234-9913 |
News Archive
Unexplained hospital factors have impact on radioactive iodine use for thyroid cancer: Study
Where thyroid cancer patients go for care plays a large role in whether they receive radioactive iodine treatment, a new study from the University of Michigan Comprehensive Cancer Center finds.
An overview of Schizophrenia and psychotic disorders
Schizophrenia and related psychotic disorders are a chronic and often disabling condition. Despite modern treatment techniques they still present an enormous burden to the patients and their relatives and take a serious toll in terms of human suffering and societal expenditure.
Roundup: Mass. lawmakers struggle to reach agreement on cost controls; $100M grant for Calif. stem cell research; N.C. to move mentally ill from elderly homes
The House and Senate are under the gun to reach an agreement on how to lower health care costs while improving care. A conference committee aims to have a bill out on Sunday. Their deadline is Monday evening. In the meantime, several major issues are still unresolved, including what to do about hospitals that use their market clout to demand high prices that are not based on higher quality. Attorney General Martha Coakley, the state's top insurers and several consumer groups argue that price is a critical issue.
New studies on personalized lung cancer treatment presented at 3rd ELCC
Several new studies that may help doctors tailor lung cancer treatment to the characteristics of individual patients and of their tumors are being presented at the 3rd European Lung Cancer Conference in Geneva.
OncoGenex terminates agreement with Teva, regains rights to custirsen
OncoGenex Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, OncoGenex Technologies Inc., executed a termination agreement with Teva Pharmaceuticals Ltd. under which OncoGenex will regain rights to custirsen, an investigational compound currently in Phase 3 clinical development as a treatment for prostate and lung cancers.
› Verified 5 days ago